Dr Marieke Kuijjer joined NCMM in October 2018 as group leader for Systems Medicine. Here she shares some insight into her career to date, and her hopes and plans for her new group at NCMM.
Professor Kjetil Taskén is head of the Signalling Networks in Health and Disease Group at NCMM. He shares some insight into his group's work with Precision Medicine and Cancer Drug Sensitivity Screening.
Johannes Landskron, Head of the Chemical Biology Platform at NCMM, shares some insight into how the platform works, and why it is so important for researchers.
The Autophagy Team at NCMM studies processes that lead to intracellular degradation of cytoplasm, collectively referred to as autophagy (Greek for "self-eating"). The team is particularly interested in the role of autophagy in aspects related to cancer.
The Mathelier Group aims to create the next generation of cutting-edge algorithms and open computational biology software, with immediate application to real-life biological problems.
The new group leader at NCMM is one of the few in the world within the research theme of surface-adhered artificial cells.
- NCMM group leaders awarded funding from the Norwegian Cancer Society Oct. 31, 2018 10:11 AM
- Professor Kjetil Taskén interviewed by the journal Fagbladet Forskningsetikk Oct. 31, 2018 8:40 AM
- Expert in genomics of human immune disorders recruited as new Director of NCMM Oct. 12, 2018 2:02 PM